NMTC

Mark Christianson

Known title: Business Development DirectorCIK: 0001709738

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

NeuroOne Reports Strong Q4 Sales, New $4.5M Order. NeuroOne Medical Technologies said its Q4 sales were about $3.8 million, up 38% from last year. The company also added a $4.5 million purchase order in September and expects FY26 sales of roughly $10.5 million, a 15.6% increase year‑over‑year. These results come as the share price sits near its 12‑touch support level of $1.63 and an RSI of 45.8.

this person other insiders at NMTC

Transaction History

NMTC▼ Sell$32K
NMTC▼ Sell$197
NMTC▼ Sell$11K
NMTC▼ Sell$80
NMTC▼ Sell$654
NMTC▼ Sell$2K
NMTC▼ Sell$9K
NMTC▼ Sell$1K
NMTC▼ Sell$192
NMTC▼ Sell$225
NMTC▼ Sell$22K
NMTC▼ Sell$172
NMTC▼ Sell$6K
NMTC▼ Sell$6K
NMTC▼ Sell$9
NMTC▼ Sell$2K
NMTC▼ Sell$5K
NMTC▼ Sell$215
NMTC▼ Sell$2K
NMTC▼ Sell$103
NMTC▼ Sell$283
NMTC▼ Sell$56
NMTC▼ Sell$87
NMTC▼ Sell$340
NMTC▼ Sell$72
NMTC▼ Sell$68
NMTC▼ Sell$274
NMTC▼ Sell$2K
NMTC▼ Sell$23K
NMTC▼ Sell$84
NMTC▼ Sell$102
NMTC▼ Sell$2K
NMTC▼ Sell$108
NMTC▼ Sell$109
NMTC▲ Buy$0
NMTC▼ Sell$113
NMTC▼ Sell$142
NMTC▼ Sell$46K
NMTC▼ Sell$9K
NMTC▼ Sell$3K
NMTC▼ Sell$14K
NMTC▼ Sell$131
NMTC▼ Sell$145
NMTC▼ Sell$81
NMTC▼ Sell$80
NMTC▼ Sell$77
NMTC▼ Sell$92
NMTC▼ Sell$108
NMTC▼ Sell$109
NMTC▼ Sell$139
NMTC▲ Buy$0
NMTC▼ Sell$145
NMTC▼ Sell$19K
NMTC▼ Sell$18K
NMTC▼ Sell$3K
NMTC▼ Sell$3K
NMTC▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.